Your PlexusDx provider can evaluate your specific case and genetic profile to determine whether combination therapy aligns with your treatment goals
LPO products can abrogate the function of PI3K specifically by caused conformational change that leads to the removal of the catalytic subunit or by competition with the regulatory subunit [111,112,113]
For instance, in November 2023, Lilly Canada, a medicine company, announced that Mounjaro (tirzepatide) is now available in Canada
Ideal candidates include adults interested in evidence-based longevity interventions, individuals seeking to optimize healthspan and biological age, patients with family histories of age-related disease, and those committed to comprehensive preventive health strategies
doi: 10.1016/j.livsci.2022.104995 29 ClareC